The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Dr. Reddy's Laboratories Ltd.  (RDY) Trade Now »     Rate RDY  -  Discuss RDY  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
83.0%
Top:
100.0%
Rate RDY:


Home
Analysis & Videos
Quotes
Bull or Bear
Discuss
        

RDY: Bull or Bear? From:    SocialPicks  |  Blogsphere  |  All

SocialPicks Community

Analysis of Generic Drug Companies from India Graphic_rating_buy RDY
Mikerun
73%
 +173.16%
in 350 days

Analysis of Generic Drug Companies from India

<>
The accompanying table includes the Top 25 rated companies with market caps over $50M U.S. Dollar which are included in the ETF Innovators [ETFI] Indian Generic Drug Index as a major component in the Global Generic Drug Index. The index also includes three companies based outside of India – Akorn (AKRX), Caraco Pharma (CPD), and Taro Pharma (TAROF).

Akorn has a joint venture with Strides Arcolab (Akorn-Strides, LLC) which is focused on the hospital market for generic injectables, dominated by Hospira (HSP) and...
By  Mike Havrilla   (+1.04%  risk: conservative)  11/24/08 Comment


A Bullish Outlook for Generic Drugs After Election Graphic_rating_buy RDY
Mikerun
73%
 -4.75%
in 20 days
(closed on 11/24/08)

A Bullish Outlook for Generic Drugs After Election

<>

In addition to the favorable underlying trends I wrote about previously for the generic drug industry, both presidential candidates are bullish on the industry with the following excerpts taken directly from their websites:

Senator Obama : Lower drug costs by allowing the importation of safe medicines from other developed countries, increasing the use of generic drugs in public programs and taking on drug companies that block cheaper generic medicines from the market.

Senator McCain : R...
By  Mike Havrilla   (+1.04%  risk: conservative)  11/04/08 Comment


Reddy lab's growing US presence Graphic_rating_buy RDY
100pureveg
29%
 +52.22%
in 978 days

...recently acquired FDA approvals for multiple life-saving drugs.

Bound to do well in this era..... when most healthy people around me seem to be righteously popping pills, and justifying their actions as 'Preventive medicine'

By  Hemant A. Sonawane   (-11.93%  risk: aggressive)  03/07/07 Comment


Great Concept Graphic_rating_buy RDY
_mg_0400
31%
 +33.41%
in 1062 days
 

Dr. Reddy's Laboratories Limited (ADR) headquarted in India. Not under the juridiction of any law for reverse research for Generic product such as Propecia.
By  bufu   (-19.83%  risk: aggressive)  12/13/06 Comment




From the Blogosphere

Dr. Reddy's Laboratories (DRY) Impressive on Both Fundamental and Technical Basis
Tradermark
34%
While I've traded Dr. Reddy's Laboratories (RDY) in the past, I have not touched it in the past few years; however as we await for the new Market Vectors Indian Small Cap fund to launch I was poking my nose around Indian stocks this weekend since the Indian market has corrected quite a bit (and rebounded from oversold levels last week).  So this name came back onto my radar in the limited universe of Indian ADRs.  (full list of Indian stocks available at TickerSpy)




Other than Bucyrus (BUCY) I cannot find a better chart, and right now it's all about charts, momentum, and liquidity so let's...
By  Trader Mark   (-7.61%  risk: moderate)  11/09/09 Comment


Analyst upgrades, downgrades and initiations: AZN, AZO, BBBY, CAH, CPN, LLL, LTD ...

Filed under: Analyst reports, Analyst upgrades and downgrades, Analyst initiations

Analyst upgrades:

<>
  • FBR Capital upgraded AutoZone (NYSE: AZO) to Market Perform from Underperform on valuation following the company's Q4 results but lowered its target on shares to $134 from $137.
  • Citigroup upgraded Calpine (NYSE: CPN) to Buy from Hold on valuation following Wednesday's sell-off. The firm believes Harbinger's share sale reflects an issue with the shareholders, not with the company, and raised its price target on the stock to $16.50 from $13.
    • <>Credit Suisse upgraded <>Knight Transportati...
    By  Eric Buscemi   (+0.00%)  09/24/09 Comment


    Mylan: Generic Drugmaker with a Strong Portfolio
    <>Mylan Pharmaceuticals (MYL) keeps coming up on my radar so I would like to take the time to analyze the stock and give some recommendations on it. Mylan is approaching its 52 week high so is it a buy or not? In October 2008, they reached a 52 week low of 5.75 and today is trading at 14.88. So that old adage of Buy Low-Sell High is coming into play. In these economic times many rules of trading are finding exceptions to that rule. Mylan's Financial picture can be found on Google Finance here. I see a good exception to Mylan's future, and see the company's stock rising based on FDA approvals ...
    By  trackseekingalpha   (-14.31%  risk: aggressive)  08/28/09 Comment


    Early Week Earnings Watch
    Tradermark
    34%
    2nd of the 3 big weeks for S&P 500 type companies arrives; last week was an unqualified success of setting expectations low, cutting expenses aggressively and beating very slow to adjust analysts expectations. Now with the bar raised higher as expectations ramped up, I expect the sledding to be a bit tougher.

    Here are names of interest in the early part of the week; with names the market will be watching and some additional ones that I like to look at. Tuesday will be the more interesting day. I forgot about earnings knee jerk reaction time, when I shorted American Express (AXP) and <>Capit...
    By  Trader Mark   (-7.61%  risk: moderate)  07/20/09 Comment


    'Compelling case' for China and India Graphic_rating_buy RDY
    +45.75%
    in 117 days

    Filed under: International markets, India, China, Newsletters, Stocks to Buy, China Mobile Limited (CHL)

    "Inflationary fears and the desire to generate higher returns in non-dollar assets should boost BRIC stocks (Brazil, Russia, India and China)," says Chuck Carlson in his The DRIP Investor.

    "Despite the run-up this year, BRIC stock markets are still reasonably valued. Russia, India, and Brazil all trade at price/earnings ratios similar to the U.S.

    <>"And while China's stock market does trade at a premium to the U.S., China's economic growth will swamp that of the U.S. this year and for the fo...
    By  Steven Halpern   (+3.28%  risk: moderate)  07/16/09 Comment



    ROCK-STAR INVESTORS
    Rank Name Sharpe Ratio Avg Return Followers
    1 noshoes 21.10 +35.23% 368
    2 Gerald Greene 18.14 +70.19% 206
    3 stockmarketfunding.com 17.66 +25.78% 53
    4 akiralegrand 13.47 +14.32% 61
    5 anup2104 12.13 +69.23% 34


    POPULAR STOCKS
    Symbol Company Name Sentiment
    SBUX Starbucks Corp
    MO Altria Group Inc
    BA The Boeing Company
    GLD streetTRACKS Gold
    XOM Exxon Mobil Corp
    SIRI Sirius Satellite Radio Inc

    TODAY'S HEADLINES

    TODAY'S TOP PICKS

    		 

    StreetInsider.com on RDY

    Visit streetinsider.com


    Discussion Wall + Add  

    Be the first to start a discussion and earn 2 points.



    More Resources

    Graphic_arrow1 About Dr. Reddy's Laboratories Ltd. - Answers.com

    Graphic_arrow1 Historical Prices - Yahoo

    Graphic_arrow1 Message Boards - BoardCentral.com

    Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




    		IN THE PRESS
    Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch